Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
AstraZeneca
Cantor Fitzgerald
Fuji
Chinese Patent Office
Teva

Generated: September 16, 2019

DrugPatentWatch Database Preview

Patent: 6,432,701

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,432,701
Title: Derived tyrosine hydroxylase gene expression system
Abstract:The invention discloses a new system for gene expression. The system is based in particular on the use of derived sequences of the first intron of the tyrosine hydroxylase gene having transcription enhancing properties. The system is particularly useful in the production of proteins in vitro, ex vivo or in vivo, particularly in gene therapy applications.
Inventor(s): Mallet; Jacques (Paris, FR), Meloni; Rolando (Paris, FR), Ravassard; Philippe (Paris, FR), Treilhou; Fabienne (Gif sur Yvette, FR)
Assignee: Aventis Pharma S.A. (Antony, FR)
Application Number:09/171,162
Patent Claims:see list of patent claims

Details for Patent 6,432,701

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Try a Free Trial Aventis Pharma S.A. (Antony, FR) 2016-04-25 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Try a Free Trial Aventis Pharma S.A. (Antony, FR) 2016-04-25 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Try a Free Trial Aventis Pharma S.A. (Antony, FR) 2016-04-25 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Fish and Richardson
Colorcon
Mallinckrodt
Federal Trade Commission
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.